On April 30, 2026, the FDA proposed formally excluding compounded semaglutide and tirzepatide from the rules that govern large-scale pharmacy compounding
To view or add a comment, sign in New insights into the endothelial glycocalyx could change how we manage patients before, during, and after surgery
Why Surgical Solutions Arent Always the Answer Sure, dermal fillers, fat grafting and facelifts can address sagging skin but they come with downtime, high costs and a risk of unnatural-looking results
However, when potential customers inquire via linked WhatsApp and Telegram channels, administrators reveal that the coaching is not fitness instruction but a coded reference to unlicensed weight-loss drugs
Dr Klapan was welcoming, thorough in her health checks, and reassuring
But this news means less than it might seem for employers